ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension (CTAF-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00461903
Recruitment Status : Completed
First Posted : April 18, 2007
Last Update Posted : December 14, 2015
Sponsor:
Collaborator:
Servier
Information provided by (Responsible Party):
Montreal Heart Institute